These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1356732)

  • 1. Total body and hepatic clearance in rats of recombinant tissue-type plasminogen activator expressed in mouse C127 and Chinese hamster ovary cells.
    Hori R; He YL; Shima T; Inui K; Aoki S; Okumura K; Tanigawara Y
    Drug Metab Dispos; 1992; 20(4):541-6. PubMed ID: 1356732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics in chimpanzees of recombinant human tissue-type plasminogen activator produced in mouse C127 and Chinese hamster ovary cells.
    Tanigawara Y; Hori R; Okumura K; Tsuji J; Shimizu N; Noma S; Suzuki J; Livingston DJ; Richards SM; Keyes LD
    Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):517-22. PubMed ID: 2110870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liver.
    Tanswell P; Heinzel G; Greischel A; Krause J
    J Pharmacol Exp Ther; 1990 Oct; 255(1):318-24. PubMed ID: 2120422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic clearance of tissue-type plasminogen activator in rats.
    Emeis JJ; van den Hoogen CM; Jense D
    Thromb Haemost; 1985 Oct; 54(3):661-4. PubMed ID: 3937264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver.
    Smedsrød B; Einarsson M
    Thromb Haemost; 1990 Feb; 63(1):60-6. PubMed ID: 2160132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activator.
    van Griensven JM; Huisman LG; Stuurman T; Dooijewaard G; Kroon R; Schoemaker RC; Kluft K; Cohen AF
    Clin Pharmacol Ther; 1996 Nov; 60(5):504-11. PubMed ID: 8941023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.
    van der Kaaden ME; Rijken DC; Kruijt JK; van Berkel TJ; Kuiper J
    Thromb Haemost; 1997 Apr; 77(4):710-7. PubMed ID: 9134648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance of t-PA, PAI-1, and t-PA-PAI-1 complex in an isolated perfused rat liver system.
    Wing LR; Hawksworth GM; Bennett B; Booth NA
    J Lab Clin Med; 1991 Feb; 117(2):109-14. PubMed ID: 1899689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of carbohydrate structure on the clearance of recombinant tissue-type plasminogen activator.
    Hotchkiss A; Refino CJ; Leonard CK; O'Connor JV; Crowley C; McCabe J; Tate K; Nakamura G; Powers D; Levinson A
    Thromb Haemost; 1988 Oct; 60(2):255-61. PubMed ID: 2851193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP technical report on toxicity studies of urethane in drinking water and urethane in 5% ethanol administered to F344/N rats and B6C3F1 mice.
    Chan PC
    Toxic Rep Ser; 1996 Mar; (52):1-91, A1-9, B1-9 passim. PubMed ID: 11803705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.
    Brommer EJ; Derkx FH; Schalekamp MA; Dooijewaard G; vd Klaauw MM
    Thromb Haemost; 1988 Jun; 59(3):404-11. PubMed ID: 3142078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of native and carbohydrate-modified tissue plasminogen activator in rabbits.
    Einarsson M; Hggroth L; Mattsson C
    Thromb Haemost; 1989 Dec; 62(4):1088-93. PubMed ID: 2515604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocytosis of the recombinant tissue plasminogen activator alteplase by hepatic endothelial cells.
    Seydel W; Stang E; Roos N; Krause J
    Arzneimittelforschung; 1991 Feb; 41(2):182-6. PubMed ID: 1904231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of human natural antibody to recombinant tissue-type plasminogen activator (t-PA) expressed in mouse C127 cells.
    Tsuji J; Noma S; Suzuki J; Okumura K; Shimizu N
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):765-8. PubMed ID: 2112046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and hepatic catabolism of tissue-type plasminogen activator.
    Tanswell P; Seifried E; Stang E; Krause J
    Arzneimittelforschung; 1991 Dec; 41(12):1310-9. PubMed ID: 1815534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of recombinant tissue factor pathway inhibitors expressed in human SK hepatoma, mouse C127, baby hamster kidney, and Chinese hamster ovary cells.
    Wun TC; Kretzmer KK; Palmier MO; Day KC; Huang MD; Welsch DJ; Lewis C; Wolfe RA; Zobel JF; Lange GW
    Thromb Haemost; 1992 Jul; 68(1):54-9. PubMed ID: 1325078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction.
    van Griensven JM; Koster RW; Burggraaf J; Huisman LG; Kluft C; Kroon R; Schoemaker RC; Cohen AF
    Clin Pharmacol Ther; 1998 Jan; 63(1):39-47. PubMed ID: 9465840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor?
    Camani C; Gavin O; Kruithof EK
    Thromb Haemost; 2000 Feb; 83(2):290-6. PubMed ID: 10739388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.